Ignite Creation Date:
2025-12-24 @ 9:27 PM
Ignite Modification Date:
2026-01-02 @ 4:18 AM
Study NCT ID:
NCT00006232
Status:
COMPLETED
Last Update Posted:
2013-05-15
First Post:
2000-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma
Sponsor:
West of Scotland Lymphoma Group
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
WSLG-H31
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None